DUSSELDORF, Germany, Nov. 12, 2024 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its latest product innovations at MEDICA ...

at Medica 2024. Valens Semiconductor Logo Based on the VA7000 chipset, the endoscopes offer a series of key benefits, including exceptional EMC reliability during electrosurgery, as well as ...

"Our latest innovations are shaped by constant feedback from clinical professionals, reflecting the importance of staying ...

Announcing a new publication for Acta Materia Medica journal. Celastrol is an active compound from the root of Tripterygium ...

Announcing a new publication for Acta Materia Medica journal. Herba Siegesbeckiae (HS) has been traditionally used for ...

LifeWallet’s Common Stock will continue to trade on the Nasdaq Global Market (“Nasdaq”) under the symbol “LIFW” and will begin trading on a split-adjusted basis when the Nasdaq opens on November 18, ...

Fapon, a global leading life sciences company, is excited to participate in the upcoming MEDICA 2024 International Trade Fair ...

New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower the risk of several diseases. Scientists at deCODE ...

Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 ...

The hotel in Argentina where One Direction star Liam Payne fell to his death Wednesday night called 911 about his destructive behavior after he had "overindulged on drugs and alcohol," according to a ...

Liam Payne, a singer who rose to fame as a member of the band One Direction, died on Oct. 16 at age 31 in Buenos Aires, Argentina. Prior to his death, Payne had struggled with addiction, sharing that ...

Upon joining, please ask to be joined into the Nephros conference call. An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page.